TLC_Tagline EN.png
TLC Announces Completion of US$23 Million Financing
June 30, 2020 05:00 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 30, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline EN.png
TLC Reports First Quarter 2020 Financial Results and Provides Business Update
May 13, 2020 04:12 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 13, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline EN.png
TLC Announces Completion of US$27 Million Financing
October 24, 2019 05:00 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 24, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline EN.png
TLC Reports Third Quarter 2019 Financial Results and Provides Business Update
October 22, 2019 06:09 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 22, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC_Tagline EN.png
TLC Appoints Vincent Chang, PhD, as Vice President of Manufacturing Development
October 20, 2019 04:10 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 20, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and...
TLC_Tagline EN.png
TLC to Present Preclinical Data on TLC178 at ESMO 2019
September 23, 2019 05:00 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 23, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and...
TLC_Tagline EN.png
TLC to Present as Panelist among Key Opinion Leaders at the BTIG Pain Management Forum
September 03, 2019 06:04 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 03, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152) announced today that the Company’s management team has been invited to participate in...
TLC_Tagline EN.png
TLC Reports Second Quarter 2019 Financial Results and Provides Business Update
July 30, 2019 06:04 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, July 30, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and...
TLC_Tagline EN.png
TLC Reports First Quarter of 2019 Financial Results and Provides Business Update
May 08, 2019 07:07 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 08, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and...
TLC_Tagline EN.png
TLC Earns Highest Ranks in Corporate Governance Evaluation for 5th Consecutive Year
May 02, 2019 06:00 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 02, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and...